- Role
- Country
- Date of registration
- Address
EUDAMED last updated this device on May 23, 2022
B-AN01637A032ANL-MF-000005790Primary placement in Netherlands; available across 20 countries total.
| Country | On market since | Until |
|---|---|---|
| NetherlandsPrimary placement | Still on market | |
| Austria | Still on market | |
| Belgium | Still on market | |
| Germany | Still on market | |
| Denmark | Still on market | |
| Estonia | Mar 5, 2024 | Still on market |
| Spain | Still on market | |
| Finland | Still on market | |
| France | Still on market | |
| Hungary | Still on market | |
| Ireland | Still on market | |
| Iceland | Still on market | |
| Italy | Still on market | |
| Luxembourg | Still on market | |
| Latvia | Apr 18, 2025 | Still on market |
| Malta | Still on market | |
| Norway | Still on market | |
| Portugal | Still on market | |
| Romania | Still on market | |
| Sweden | Still on market |
European Medical Device Nomenclature — the EU product classification assigned to this device.
W0103010504HAEMOGLOBIN CONTROLSNo certificates registered for this manufacturer.
No certificate references this Basic UDI-DI, because: • It does not require a certificate, or • It only requires a certificate without a Basic UDI-DI reference (e.g. a QMS certificate), or • The required certificate(s) referencing this Basic UDI-DI have not been registered yet.